Company & Sponsor Intelligence

University of British Columbia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting2

Completed5

Countries1

Therapeutic footprint

adhddementia_otherdepressionparkinsonsstroke

Indexed studies

NCT02982252Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 2)
dementia_other · CanadaNA

NCT00885807A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)
adhd · CanadaCOMPLETED

NCT07443293IMPACT 360 for Parkinson's Disease
parkinsons · CanadaPHASE2

NCT06915987Parkinson Disease and Exercise Snacks
parkinsons · CanadaNA

NCT02167048Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
adhd · CanadaPHASE1, PHASE2

NCT00434928Dietary Intake and Nutrient Status of Children With ADHD
adhd · CanadaCOMPLETED

NCT06573125A Feasibility and Preliminary Efficacy Study of an App-Based Physical Activity Intervention (MoodMover) for Depression
depression · NA

NCT02654951Reaching in Stroke
stroke · CanadaNA

NCT01915368Determining Optimal Post-Stroke Exercise (DOSE)
stroke · CanadaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →